1 / 7

Cost-Effectiveness Analysis of Maternal Micronutrient Supplementation in <COUNTRY>

[logo of the institution]. Cost-Effectiveness Analysis of Maternal Micronutrient Supplementation in <COUNTRY>. <DATE>. The information in this presentation comes from a tool developed by Nutrition International, accessible at: www.nutritionintl.org/mms-cost-benefit-tool/

matchett
Download Presentation

Cost-Effectiveness Analysis of Maternal Micronutrient Supplementation in <COUNTRY>

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. [logo of the institution] Cost-Effectiveness Analysis of Maternal Micronutrient Supplementation in <COUNTRY> <DATE>

  2. The information in this presentation comes from a tool developed by Nutrition International, accessible at: www.nutritionintl.org/mms-cost-benefit-tool/ The tool is based on research by:Kashi B, Godin CM, Kurzawa, ZA, Verney AMJ, Busch-Hallen, JF, De-Regil, LM. Multiple Micronutrient Supplements are more cost-effective than Iron and Folic Acid: Modeling results from 3 high-burden Asian countries. J Nutrition. 2019 (May). Decision? Should <COUNTRY> transition from Iron and Folic Acid Supplementation (IFAS) to Multiple Micronutrient Supplementation (MMS) for antenatal programming?

  3. Health Impacts of Transitioning from IFAS to MMS The transition will avert an additional <> Disability Adjusted Life Years (DALY) The transition will prevent the deaths of an additional <>children * Prospective health outcomes over <10> years

  4. Cost-Effectiveness and Investment Case Benefits of transitioning from IFAS to MMS are <>time greater than the costs The transition can be considered <> according to WHO guidelines (Leech et al., 2018) 1

  5. Budget Impact of Transitioning Value of DALYs averted <> Additional investment over <10> years <>

  6. Key Assumptions • Population of pregnant women each year - <> • Timespan (length of the supplementation program over which costs and benefits are counted) - <> years • Coverage: Proportion of pregnant women reached by program - <>% • Supplement costs per beneficiary for IFAS and MMS (180 supplements) • IFAS - $<> (2016 USD) • MMS - $<> (2016 USD) • All other costs associated with transition - $<> (2016 USD) • Source of assumptions about relative risk of various health outcomes • Keats et al. 2019 (Cochrane) or Smith et al. 2017 (Lancet)

  7. References Kashi B, Godin CM, Kurzawa, ZA, Verney AMJ, Busch-Hallen JF, De-Regil LM. Multiple Micronutrient Supplements are more cost-effective than Iron and Folic Acid: Modeling results from 3 high-burden Asian countries. J Nutrition. 2019;149:1222-1229. Available from: doi.org/10.1093/jn/nxz052 Keats EC, Haider BA, Tam E, Bhutta ZA. Multiple‐micronutrient supplementation for women during pregnancy. Cochrane Database of Systematic Reviews. 2019: Issue 3. Art. No: CD004905. Available from: DOI:10.1002/14651858.CD004905.pub6. Leech AA, Kim DD, Cohen JT, Neumann PJ. Use and Misuse of Cost-Effectiveness Analysis Thresholds in Low- and Middle-Income Countries: Trends in Cost-per-DALY Studies. Tufts Medical Center, 2018; Boston, MA, USA. Available from: doi.org/10.1016/j.jval.2017.12.016. Smith, ER, Shankar AH, Wu LS-F, Said A, Seth A-A, Hasmot A, Rina A et al. Modifiers of the effect of maternal multiple micronutrient supplementation on stillbirth, birth outcomes, and infant mortality: a meta-analysis of individual patient data from 17 randomised trials in low-income and middle-income countries. Lancet Glob. Health. 2017; 5: e1090–e1100.

More Related